当前位置：
X-MOL 学术
›
Clin. Neuropharmacol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Changes of Serum C-Reactive Protein Level in Patients With Depressive Disorders After Treatment With Agomelatine Combined With Aerobic Exercise and Its Significance.
Clinical Neuropharmacology ( IF 1 ) Pub Date : 2023-09-12 , DOI: 10.1097/wnf.0000000000000568 Zhuping Sun 1 , Silu Chen 2 , Hui Zhang 2 , Xiaoqing Gu 3 , Haiyan Ge 4 , Jinglei Chen 5
Clinical Neuropharmacology ( IF 1 ) Pub Date : 2023-09-12 , DOI: 10.1097/wnf.0000000000000568 Zhuping Sun 1 , Silu Chen 2 , Hui Zhang 2 , Xiaoqing Gu 3 , Haiyan Ge 4 , Jinglei Chen 5
Affiliation
Depressive disorders constitute a series of debilitating diseases. This study investigated the therapeutic effect of agomelatine (AG) combined with aerobic exercise (AE) on patients with moderate-severe depression (MSD) and the changes of the serum C-reactive protein (CRP) level in patients after treatment as well as its significance.
中文翻译：
阿戈美拉汀联合有氧运动治疗抑郁症患者血清C反应蛋白水平的变化及其意义。
抑郁症是一系列使人衰弱的疾病。本研究探讨阿戈美拉汀（AG）联合有氧运动（AE）对中重度抑郁症（MSD）患者的治疗效果及治疗后患者血清C反应蛋白（CRP）水平的变化及其治疗效果。意义。
更新日期：2023-09-12
中文翻译：
阿戈美拉汀联合有氧运动治疗抑郁症患者血清C反应蛋白水平的变化及其意义。
抑郁症是一系列使人衰弱的疾病。本研究探讨阿戈美拉汀（AG）联合有氧运动（AE）对中重度抑郁症（MSD）患者的治疗效果及治疗后患者血清C反应蛋白（CRP）水平的变化及其治疗效果。意义。
京公网安备 11010802027423号